For Immediate Release

Event management and market research company hits the big time

Bristol, United Kingdom, November 15^th, 2010 – Marketing, events and market research company Sector Marketing (www.sectormarketing.co.uk) has hit the big time with its impeccable, organised international event management service. Sector Marketing offers conference management and exhibition management– delivering, in its event management arm alone, conferences; receptions; award ceremonies; trade missions (both inward trade and outward trade); road shows; briefing courses; and seminars. Because Sector Marketing covers such a wide range of all round marketing areas in its whole business plan, the company is uniquely placed to take care of absolutely everything that goes into an international event management project – from market research and initial idea storming all the way through to taking the show down at the end of its running period.

Sector Marketing offers the following bespoke services for all its international events: design and production; registration; security and management; logistics; marketing; PR; sponsorship; filming; multi media event presence creation; stage design; stage building; technical support; venue sourcing; audience recruitment; graphic design; copywriting and script writing; and of course market research. The phenomenal success of the company’s international events, which have spanned conferences, trade fairs, exhibitions and one off events, is entirely due to the fact that its multi national makeup allows it to easily source and run staff, kit, technical apparatus and venues anywhere in the world.

The international event management contracts won by Sector Marketing are multiplying thanks to the company’s combination of effective management skills and second to none market research. The key, as ever, lies in sourcing the right prospects to attend the right events – and when a company has cut its teeth on researching markets, all of that comes as second nature.

Contact Details:

Lower Strode Road,

Clevedon, Bristol,

BS21 6UU

Web site : www.sectormarketing.co.uk

###

Latest translation and localization industry research report from Common Sense Advisory shows the majority of transcreation projects relate to international marketing and advertising.

BOSTON, MA – April 12, 2010 — As companies attempt to sell their products and services to more demographics in more markets around the world, they are discovering that they must adapt or recreate their messaging and content through a process called “transcreation.” A new report from market research firm Common Sense Advisory, “Reaching New Markets through Transcreation,” confirms growing demand for transcreation services through 2010.

The firm’s survey of 380 language services industry respondents revealed that transcreation is not only here to stay, but on the rise. Twenty-five percent of those surveyed stated that they expect transcreation – as a percentage of total translation activities – to grow between six and 10 percent during 2010, while almost 30 percent anticipate that it will increase by more than 10 percent.

Common Sense Advisory’s enterprise globalization strategist Rebecca Ray notes, “The key word is resonance in local markets – whether it’s a market defined by geography or one defined by language and culture within a larger domestic market.”

The report details how the “internet of things” – mobile devices, cars, cameras, appliances, roadways, and pipelines – projected to be composed of a trillion devices by 2011, is a key driver for the increase in transcreation demand.

The report also includes:

* Analysis of data from 380 survey respondents related to the various definitions of transcreation, growth in demand, industries that purchase transcreation most frequently, types of content where transcreation is most common, who owns the budget, and how the services are priced
* Insights from 30 interviews with decision makers and practitioners on how to build and maintain the transcreation ecosystem, adapt workflow, and ensure quality
* Why transcreation is just as relevant in home markets as in foreign markets
* Implications for SEO
* Ten steps that will enable buyers to achieve transcreation quality

International businesses and providers of translation and localization services can benefit from knowing when, why, and how to incorporate transcreation into their workflows and product offerings.

Adds Ms. Ray, “Over the last five years, the larger buyers of language services have focused on rationalizing and automating the globalization function within their organizations. One of the most important findings that emerged from our research is that this investment now allows more budget for the transcreation of strategic content that can really impact their bottom line.”

“Reaching New Markets through Transcreation” is the latest in a series of research reports produced by Common Sense Advisory that focus on transcreation and international marketing.

About Common Sense Advisory
Common Sense Advisory, Inc. is an independent research firm specializing in the online and offline operations driving business globalization, internationalization, translation, interpretation, and localization. Its research, consulting, and training help organizations improve the quality of global business. For more information about Common Sense Advisory’s research, reports, and globalization and localization consulting services. www.commonsenseadvisory.com.

Contact:
Melissa Gillespie
Common Sense Advisory
Lowell, MA 01852
100 Merrimack St.
+1 760-522-4362
[email protected]

http://www.commonsenseadvisory.com

Any smart grid is a telecommunications network for the utility and the communities it serves. 4G technologies provide any power utility with the most cost effective technology in monitoring the grid from power production to power consumption. Not only will a 4G smart grid read meters, they will also provide a range of cost saving services to the utility and the community as a whole. Mind Commerce’s new research 4G and WiMAX for the Smart Grid: Enabling Access, Applications and Affordability proposes WiMAX as a Last Mile or “Access” solution to provide a range of smart grid solutions or “Applications” which, when compared with other smart grid technologies such as Broadband over Power Line (BPL) come in at less than half the cost per household reached offering industry leading “Affordability” figures.

The research indicates that given the dilemma of US Department of energy awarding billions of dollars in smart grid grants while standards making bodies dither in providing the industry with standards, the power industry should look to the latest and greatest standards in telecommunications (Internet Protocol and 4G technologies such as WiMAX) to take advantage of federal dollars available for smart grid deployments while saving money on operating expenses. In addition, the deployment of a 4G network would enable the utility to offer wholesale and retail telecommunications services contributing new revenue streams for the utility while shortening the Return on Investment (ROI).

Any utility manager studying their smart grid options is no doubt concerned about the security of any smart grid network (foreign agents have been known to attempt to hack some parts of the US power grid), Quality of Service (QoS) issues, reliability of the technology and the potential for harmful interference to take down their smart grid network. This publication tackles those objections head-on in easy-to-understand language addressing both Last Mile and Middle Mile portions of a 4G smart grid network.

Most importantly, the paper analyses a BPL deployment in Boulder, Colorado where the power utility deployed a BPL-based smart grid at a cost of $1,000 per household reached. The research finds that a more powerful, mobile, 4G, standards-based network could have been deployed at a cost of $440 per household reached. The financial analysis offers a worksheet for power utilities to determine return on investment.

With its exhaustive analysis of 4G and smart grid, there is no other research currently available as comprehensive as 4G and WiMAX for the Smart Grid: Enabling Access, Applications and Affordability.

Key Findings:

4G Smart Grid can be deployed at half the cost of broadband over Power Line (BPL) via an off-the-shelf solution
Incremental revenue streams can be enjoyed via wholesaling telecommunications services supported by 4G smart grid applications
4G smart grid solutions provide utilities with cost savings on internal operations (mobile work force applications, etc)
Ubiquitous broadband services can be realized through the deployment of 4G in the power utilities’ market providing greater efficiencies for smart grid subsidies

Target Audience:

Power utilities companies
Renewable energy companies
Telecommunications service providers
Telecommunications vendors seeking entry to the smart grid market
Government regulatory authorities
Power sector vendors
Telecommunications and utility investors

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1068/4G-and-WiMAX-for-the-Smart-Grid-Enabling-Access-Applications-and-Affordability.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: [email protected]
Website : www.visionshopsters.com

Outsourcing Web Research offers a complete variety of web research solutions to different industries and businesses. Our expertise in knowledge management and web research services helps us carve out customized research solutions for our clients. A few of them are listed below.

Web Data Mining and listing
Address and E-mail compilation
Database Building
Populate database of E-commerce
Websites/Online stores through
Web research and product research
Market research
Web survey and analysis
Updating Lists
Validation of addresses
Enhancement of Customer List

We provide web research services for all your business specific requirements and stay on constant touch with you for instructions, status updates and accomplish the requirement within the given time and with high accuracy.

You can use our FREE Trial Offer for any web research services for first few hours. No hidden Charges and you can test our accuracy and fast web research services.

We carry out the whole procedure from scratching to creating your own significant database. Outsourcing Web Research is one of the best business processing outsourcing organizations in the business.

Outsourcing Web Research has best infrastructure includes 200+ workstations supported by advanced technologies for operational efficiency and optimum security of your data and information. To get more information about our web research services, please contact us at: http://www.outsourcingwebresearch.com/contactus.php OR e-mail us at: [email protected]

CEP is a high potential market, the growth of which is directly related to the global GDP, trade and population. The CEP market is an important part of the overall transportation and distribution industry and reflects the global industrial state and the growth therein.

Globally, CEP market is growing at different paces. On one hand, there is the matured market of the US, while on the other; there are markets which are still underdeveloped. The Asian market holds tremendous growth potential. With China being the most promising market in Asia, opening up opportunities for foreign companies and India picking up the pace, the Asian region is set to grab the limelight in the near future. Markets in Asia are flourishing due to the growing trade between India and China.

The worldwide CEP market is dominated by the four large delivery companies FedEx, UPS, DHL and TNT. The main target of all these companies is to strengthen their networks through their international alliances, agreements, strategic acquisitions and by exploring newer markets.

The report discusses the global CEP market and highlights the growth and characteristics of the various regional markets and countries. The report covers the major markets – US, Europe, and Asia. The report also profiles the four major express delivery companies, focusing in-depth on their business strategies. It also highlights the major trends and issues prevalent in the market.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

For more information, please visit :
http://www.aarkstore.com/reports/Global-Courier-Express-Parcel-CEP-Market-2009-Edition-647.html
Or email us at [email protected] or call +919272852585

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

• Needle-free drug delivery

• Other Injectable/Implantable

Unique analysis offers segmentation of this market for:

• Drug Delivery Technology Revenues

• Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

• Detailed Profiles of Key Companies in Implantable/Injectable Delivery

• Brief Round-Up of Smaller Players

• Current Market Size and Forecasts to 2013

• Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments

• Revenue Forecasts

• New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

• Alkermes, Inc.

• ALZA Corp.

• Antares Pharma, Inc.

• Bioject Medical Technologies, Inc.

• CyDex, Inc.

• MGI Pharma, Inc

• Nektar Therapeutics

• Pacira Pharmaceuticals, Inc.

• pSivida

• SurModics, Inc

• Zogenix Corporation

• AP Pharma

• Baxter BioPharma Solutions

• QLT USA, Inc

• Ypsomed Holding AG

Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.

For more information, please visit :
http://www.aarkstore.com/reports/Drug-Delivery-Markets-Implantable-Injectable-and-Needle-Free-Delivery-Systems-28096.html
Or email us at [email protected] or call +919272852585

The term “companion biomarker” means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disease have long played an important role in diagnostic medicine as evidenced by the intense use of specific clinical laboratory tests in the diagnosis of disease. Biomarkers can be used in five very distinct ways in drug development: 1) companion biomarkers can be correlated with biological events during drug development in order to validate drug targets or to predict drug response; 2) biomarkers can be used as companion diagnostics in drug development to characterize patient populations in order to better understand the extent to which new drugs reach intended therapeutic targets can alter proposed therapeutic pathways and achieve successful clinical outcomes; 3) biomarkers can be used to stratify patient populations for drug response in primary prevention or disease-modification studies, particularly in specific clinical areas such as neuron degeneration and cancer; 4) clinically useful biomarkers are becoming increasingly useful to make proper therapeutic decisions regarding candidate drugs; and 5) clinically useful biomarkers are becoming increasingly required by the FDA and other outside authorities to make proper regulatory decisions regarding candidate drugs. This report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. The emphasis is on those companies that are actively developing and marketing new companion diagnostic tests for performing biomarker tests during drug development, as opposed to the more routine and clinically accepted companion markers that are manufactured and marketed by large diagnostic companies for routine clinical use.

Table of Contents :   1. Overview 13
1.1 Statement of Report 13
1.2 About This Report 13
1.3 Scope of the Report 13
1.4 Objectives 13
1.5 Methodology 15
1.6 Executive Summary 16

2. Introduction: Companion Diagnostics in Drug Development 19
2.1 Companion Diagnostics as Biomarkers 20
2.1.1 Potential Benefits of Biomarkers as Companion Diagnostics 22
2.2 Biomarkers in Different Phases of Drug Development 22
2.2.1 Drug Discovery and Development Process 22
2.2.2 Biomarkers in Drug Development 24
2.3 Drug Targets 24
2.3.1 Target Discovery Using Functional Genomics 26
2.3.2 Functional Genomics 26
2.3.3 Target Validation 28
2.3.3.1 Target Discovery 28
2.3.3.2 Lead Identification 28
2.3.4 Target and Biomarker Discovery 29
2.3.4.1 Biomarker Validation 29
2.4 Biomarkers in Drug Discovery, Development and Clinical Diagnostics 29
2.4.1 Role of Biomarkers in Drug Discovery, Preclinical, Clinical Development and Diagnostics 29
2.4.2 The Pipeline Problem 31
2.4.3 Biomarkers in the Drug Discovery Process 32
2.4.4 Segmentation of Biomarker Usage 32
2.4.5 Efficacy of Biomarkers as Surrogate Endpoints 33
2.4.6 Biomarkers Used to Reduce the Cost of Drug Development 34
2.4.7 Biomarkers: Challenges and Opportunities 34
2.4.8 Biomarkers in Early Safety and Toxicity Assessment 35
2.4.9 Biomarkers in Determining Validation Parameters 35
2.4.10 Challenges in Development of Biomarkers 36
2.4.11 Using Biomarkers in Early Clinical Development 36
2.4.12 Translational Biomarkers 36
2.4.13 Use of Biomarkers in “Go”/No-Go” Decisions 37
2.4.14 Diagnostic Tests 37
2.4.15 Biomarkers in Deal Making 37
2.4.16 Payors Use Biomarkers in Decision-Making 37
2.5 World Pharmaceutical Markets 38
2.5.1 World Market Summary 38
2.5.2 Company Performance in this Segment 40
2.5.3 Forces Affecting the Structure of the Pharmaceutical Industry 41
2.5.3.1 Threats 41
2.5.3.2 Competitive Forces 42
2.6.1 Industry Overview 42
2.6.1.1 Pharmaceutical Industry Drug Pipeline 44
2.6.1.2 Asia-Pacific to Replace United States and Europe as Pharmaceutical Industry Center 54
2.6.1.3 The Changing Pharmaceutical Business Model 54
2.6.2 Benefits for Companion Diagnostic Tests in Drug Development 55
2.6.3 Strategies for the Creation of Partnerships – Predicting and Overcoming Challenges in Creating Drug Response Profiling Diagnostics 57
2.6.4 Options and Applications 57
2.6.4.1 Clinical Applications of Genomics: The Use of Evidence Based Frameworks by Decision-Makers 57
2.6.5 Challenges, Drivers and Trends 58
2.6.5.1 Macro Trends in Biomarkers 58
2.6.5.2 Biomarkers: Industry SWOT Analysis 61
2.6.6 Breakaway Technologies 62
2.6.7 Collaboration for Companion Diagnostics 63
2.6.8 Key Stake Holders in Companion Diagnostics 63
2.9 Future Developments 65

For more information, please visit :
http://www.aarkstore.com/reports/Companion-Biomarkers-in-Drug-Development-13521.html
Or email us at [email protected] or call +919272852585

The purpose of this TriMark Publications report is to describe the sector trends within the point of care testing (POCT) diagnostic market. It examines those measurement devices and their reagents and supplies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the purpose of diagnosis and monitoring of disease. This study includes all of the generally-accepted clinical analytical activities that are currently in use today. Additionally, an analysis of business and technology trends and developing areas of point of care and HPV testing is provided, along with a review of the market for point of care testing equipment and supplies in the clinical and research market segments, using screening reagents and instruments for analysis of individual components in blood, serum or plasma. This report defines U.S. and global market dollar sales volume and analyzes factors that influence the size and growth of market segments.

Table of Contents : 1. Overview 6
1.1 Statement of Report 6
1.2 Scope of the Report 8
1.3 Objectives 9
1.4 Methodology 9
1.5 Executive Summary 10

2. Overview of Diagnostic Point of Care Testing 12
2.1 Key Issues in the Point of Care Diagnostic Testing Sector 12
2.1.1 Current Market Trends and Drivers 12
2.1.2 Effectiveness of POCT 13
2.1.3 New Growth Areas for POCT 14
2.1.4 Advantages of POCT in a Clinical Setting 14
2.1.5 Pricing and Reimbursement Issues 14
2.1.6 Key Customer Segments 14
2.2 Global Point of Care Marketplace 14
2.3 Shifts from Central Lab Testing to POCT 16
2.4 Geographical Distribution 16
2.5 Emerging New Technologies 17
2.6 Challenges of POCT 18
2.7 Key Issues for POCT 18
2.7.1 Locations of POCT 18
2.7.2 Hospital Lab Rapid Tests 19
2.7.3 Doctor’s Office Laboratory 19
2.7.4 Non-Hospital POCT 19
2.7.5 Home Monitoring 19
2.7.6 Milestones in Technology Development 20
2.7.7 Drive for Decentralization from Lab to Patient 21
2.7.8 Expanded Reimbursement 21
2.7.9 Competitive Landscape for POCT 24
2.8 The Future of POCT 24

For more information, please visit :
http://www.aarkstore.com/reports/Point-of-Care-Diagnostic-Testing-Sector-Trends-1333.html
Or email us at [email protected] or call +919272852585

The purpose of this Publications (http://www.aarkstore.com/reports/Over-the-Counter-Diagnostic-Products-World-Markets-1331.html) analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their reagents and supplies that are utilized in clinics and by patients directly in their homes to diagnose and monitor disease. This study also includes a review of home healthcare kits and devices that measure health-related conditions. Focus is on market dynamics and current market drivers of the OTC and home self-testing diagnostics market. This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market share. The analysis covers healthcare-related devices that are designed for the home market in order to allow consumers to assess their health status through self-testing. In addition, this review examines some biowarfare detection systems. The emphasis in this report is on those companies and products that are actively developing and marketing diagnostic reagents and supplies in market segments that are targeted for direct sale to the public. It is believed that this market segment has the potential for growth rates above 15% per year over the next five years in some of the less well-explored and well-developed areas.

Table of Contents : 1 Overview 7
1.1 Statement of Report 7
1.2 About This Report 7
1.3 Scope of the Report 9
1.4 Objectives 10
1.5 Methodology 11
1.6 Executive Summary 11

2 Sector Overview 17
2.1 Global Diagnostic Products Industry 17
2.2 Global OTC Diagnostic Products Industry 18
2.2.1 General Global Market 18
2.2.2 German OTC and Home Self-Testing Diagnostic Markets 22
2.2.3 U.K. OTC and Home Self-Test Diagnostic Markets 22
2.2.3.1 U.K. Market Statistics 23
2.2.3.2 U.K. Competitive Analysis 24
2.2.3.3 U.K. Market Access 25
2.2.4 French OTC Diagnostic Market 25
2.2.5 Italian OTC Diagnostic Market 26
2.2.6 Spanish OTC Diagnostic Market 26
2.2.7 Japanese OTC Diagnostic Market 27
2.2.8 Chinese OTC Diagnostic Market 28
2.3 Description of the U.S. OTC Diagnostics Industry Segment 29
2.3.1 Market Overview 29
2.3.2 Diagnostic Test Categories 30
2.4 Market Drivers in the OTC Diagnostics Sector 31
2.4.1 Overview 31
2.4.2 Market Segments 31
2.5 Key Players in the OTC Diagnostics Segment 32
2.6 Sector Analysis 34

3 Market Analysis: Size, Growth, Share and Competitors 35
3.1 Glucose Monitoring 35
3.1.1 Glucose Control in Diabetic Patients 41
3.1.2 Tight Glucose Control in Treating Diabetes 41
3.1.3 Glucose-Monitoring Devices 42
3.1.4 Key Issues for Glucose Monitoring 43
3.1.5 Glucose Device Description 43
3.1.6 Precision in Glucose Meters 44
3.1.7 Limitations of Existing Glucose Monitoring Products 45
3.1.8 Over-the-Counter (OTC) Self-Testing Glucose Market 46
3.1.9 Worldwide Glucose Testing Market 48
3.1.9.1 U.S. Market 49
3.1.9.2 European Market 53
3.1.9.3 Asian Market 54
3.1.9.3.1 Japanese Market 55
3.1.9.3.2 China Market 56
3.1.9.3.3 Indian Market 58
3.1.9.4 ROW Markets 59
3.1.10 Reagents and Equipment 59
3.1.10.1 Blood Glucose Monitoring 59
3.1.10.2 Lancets 60
3.1.10.3 Blood Glucose Monitor and Insulin Doser 67
3.1.10.4 Blood Glucose Reagent Test Strips 67
3.1.10.5 Control Solutions and Calibrators 68
3.1.10.6 Sharps Devices 68
3.1.10.7 Needle Destruction Devices 69
3.1.10.8 Voice-Operated Glucose Meters 70
3.1.11 Glucose Meters 73
3.2 Pregnancy Testing 98
3.2.1 Major Players 99
3.2.1.1 U.S. Market 100
3.2.1.2 European Market 101
3.2.2 Diagnostic Kit Information 101
3.3 Hepatitis Testing 108
3.4 Drugs of Abuse Screening Testing 111
3.5 Infectious Disease Testing 126
3.5.1 HIV 128
3.5.2 Tuberculosis Testing 139
3.5.3 Infectious Disease Testing in Non-medical Settings 140
3.5.4 West Nile Virus 142
3.5.5 Urinary Tract Infections 143
3.6 Cholesterol Testing 144
3.7 Coagulation Testing 146
3.8 Urine Dipstick Testing 153
3.9 Fertility Testing 153
3.9.1 Players 155
3.9.2 Diagnostic Test Kits 156
3.10 At-Home DNA Analysis 159
3.11 Biowarfare Detection 164
3.12 Home Patient Monitoring Devices 166
3.13 Home Patient Alert Systems 167
3.14 Home Genetic Testing Kits 167
3.15 Home Paternity Testing 171
3.16 Health Hazards Detection 172
3.16.1 Lead 172
3.16.2 Radon 172
3.16.3 Asbestos 172
3.16.4 Pesticides 173
3.16.5 Mold 173
3.16.6 Carbon Monoxide 173
3.16.7 Water Quality 173
3.16.8 Bacteria in Water 173
3.17 Thyroid Disease 174
3.18 Carpal Tunnel 174
3.19 Allergies 174
3.20 Nutrition and Wellness 174
3.20.1 Testosterone and Male Hormones 174
3.20.2 Female Hormones 174
3.20.3 Antioxidants 174
3.20.4 Sleep Apnea 175
3.20.5 Mineral Check 175
3.20.6 Stress Check 175
3.21 Colorectal Cancer (Occult Blood) Testing 176
3.22 Alzheimer?s Disease Home Screening Test 177
3.23 Tobacco Testing 177

For more information, please visit :
http://www.aarkstore.com/reports/Over-the-Counter-Diagnostic-Products-World-Markets-1331.html
Or email us at [email protected] or call +919272852585

This Publications report (http://www.aarkstore.com/reports/Disposable-Medical-Supplies-Markets-1507.html) is intended to provide basic marketing data pertaining to the U.S. and worldwide market segments of the disposable medical supplies market, including: surgical gowns, surgical drapes, isolation gowns, surgical and examination gloves, institutional incontinence disposables, operating room (OR) custom kits and trays, non-OR custom packs, shoe covers, masks, disposable coveralls and lab coats, headwear, protective eyewear, sterile wipes, swabs and mops. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Growth rates and sales projections are reported in units and U.S. dollars. Market shares are based on units and apply to the U.S. only.

Table of Contents : 1. Introduction 10
1.1 Objectives 10
1.2 Scope 10
1.3 Methodology 11
1.4 Executive Summary 12

2. Disposable Medical Supplies Market 14
2.1 Overview 14
2.2 Technological Advancements in Disposable Medical Supplies 14

3. Nanotechnology in Medical Devices and Disposables 15
3.1 Implants 16
3.2 Tissue Engineering 16
3.3 Sensors 16
3.4 Stents 16
3.5 Nanostructured TiOx Ultra Thin Films 16
3.6 Drug Delivery 17
3.7 Heat Therapy 17
3.8 MRI/X-ray 17
3.9 Bone Cement 17

4. Medical Design Excellence Awards for Medical Disposables 18
4.1 Winning Disposable Medical Products and Suppliers, 2008 18
4.1.1 HemCon® Bandage 18
4.1.2 Veramyst™ (Fluticasone Furoate) Nasal Spray Delivery Device 19
4.1.3 Akreos® AO Microincision Lens, Model MI60 19
4.1.4 GeeWhiz Male External Condom Catheter 19
4.1.5 Natural Nurser™ Baby Bottle 20
4.1.6 NovoFine® Autocover™ Automatic Safety Pen Needle 20
4.1.7 Uresta™ Continence Care Kit 20
4.1.8 InteguSeal™ Microbial Sealant 21
4.1.9 Patient Registration Mask 21
4.2 Winning Disposable Medical Products and Suppliers in 2007 21
4.2.1 Thermoplastic Drill Template Set 21
4.2.2 Ospol Dental Implant System Packaging 22
4.2.3 Episure™ AutoDetect Epidural Syringe 22
4.2.4 Odor Absorbing Hydrocolloid Wound Dressing 23
4.2.5 SureSkin® Central Catheter and I.V. Dressing 23
4.2.6 Gynecare TVT Secur™ System for Treating Stress Urinary Incontinence 23
4.2.7 Conveen® Optima Silicone Urisheath 24
4.3 Winning Disposable Medical Products and Suppliers, 2006 24
4.3.1 eFlow® Electronic Nebulizer 24
4.4 Winning Disposable Medical Products and Suppliers, 2005 24
4.4.1 OptraGate® 24
4.4.2 RelyX™ Luting Plus Cement 25
4.4.3 3M™ Foam Adhesive Dressing 25
4.4.4 ClozeX Wound Closure Device 25

5. Overview of Non-woven Industry 26
5.1 Future of Global Non-woven Production 31
5.2 U.S. Non-woven Market 33
5.3 Non-woven Production in Europe 34
5.3.1 Non-woven Industry in Turkey 34
5.4 Non-woven Industry in Asia 35
5.4.1 India is the Next Booming Market for Non-wovens 36
5.5 Non-wovens in Medical Sector 39
5.6 U.S. Medical Non-woven Market 43
5.7 Characteristics of the Medical Textile Market 45
5.8 Trends in World Trade of Medical Textiles 47

6. Surgical Gowns 49
6.1 Size and Growth Rate of the Market 49
6.2 Company Profiles 52
6.2.1 Kimberly-Clark HealthCare 52
6.2.2 Cardinal Health Corp. 53
6.2.3 Medline Industries, Inc. 53
6.2.4 Mölnlycke HealthCare 53
6.2.5 Johnson & Johnson 54
6.2.6 Dynarex Corporation 54
6.2.7 3M HealthCare 55
6.3 Competition in the Medical Gown Market 55
6.4 Overall Trends 56

For more information, please visit :
http://www.aarkstore.com/reports/Disposable-Medical-Supplies-Markets-1507.html
Or email us at [email protected] or call +919272852585